University of California granted another CRISPR patent
UC Berkeley announced Tuesday it received a patent for a single-molecule guide RNA that can be used with the Cas-9 enzyme by the gene-editing tool CRISPR in plants, bacteria and mammalian cells.
Why it matters: Discovering new methods of making CRISPR’s gene editing more precise are key to its future success in modifying crops and treating diseases. But, there’s also a race among institutions — especially between UC and the Broad Institute — to own CRISPR patents that are potentially worth billions, per Reuters.
